115 related articles for article (PubMed ID: 9143865)
1. Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Community pharmacists of the Midi-Pyrénées.
Lapeyre-Mestre M; Damase-Michel C; Adams P; Michaud P; Montastruc JL
Eur J Clin Pharmacol; 1997; 52(1):37-9. PubMed ID: 9143865
[TBL] [Abstract][Full Text] [Related]
2. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey.
Boeuf O; Lapeyre-Mestre M;
Drug Saf; 2007; 30(3):265-76. PubMed ID: 17343432
[TBL] [Abstract][Full Text] [Related]
3. A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions.
Lapeyre-Mestre M; Gony M; Carvajal A; Macias D; Conforti A; D'Incau P; Heerdink R; Van der Stichele R; Bergman U
Eur Addict Res; 2014; 20(4):174-82. PubMed ID: 24458222
[TBL] [Abstract][Full Text] [Related]
4. Use of prescription forgeries in a drug abuse surveillance network.
Bergman U; Dahl-Puustinen ML
Eur J Clin Pharmacol; 1989; 36(6):621-3. PubMed ID: 2776820
[TBL] [Abstract][Full Text] [Related]
5. Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion.
Jouanjus E; Guernec G; Lapeyre-Mestre M;
Fundam Clin Pharmacol; 2018 Jun; 32(3):306-322. PubMed ID: 29436015
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in France.
Orriols L; Gaillard J; Lapeyre-Mestre M; Roussin A
Drug Saf; 2009; 32(10):859-73. PubMed ID: 19722729
[TBL] [Abstract][Full Text] [Related]
7. Abuse of prescription medicines in southwestern France.
Baumevieille M; Haramburu F; Bégaud B
Ann Pharmacother; 1997; 31(7-8):847-50. PubMed ID: 9220042
[TBL] [Abstract][Full Text] [Related]
8. Detecting the diverted use of psychoactive drugs by adolescents and young adults: A pilot study.
Jouanjus E; Falcou A; Deheul S; Roussin A; Lapeyre-Mestre M
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1286-1292. PubMed ID: 30255533
[TBL] [Abstract][Full Text] [Related]
9. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.
Frauger E; Pauly V; Pradel V; Rouby F; Arditti J; Thirion X; Lapeyre Mestre M; Micallef J
Fundam Clin Pharmacol; 2011 Oct; 25(5):633-41. PubMed ID: 21077937
[TBL] [Abstract][Full Text] [Related]
10. Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio.
Llau ME; Lapeyre-Mestre M; Plas L; Damase-Michel C; Montastruc JL
Eur J Clin Pharmacol; 2002 Feb; 57(12):911-2. PubMed ID: 11936712
[No Abstract] [Full Text] [Related]
11. Abuse and Misuse of Prescription and Nonprescription Drugs from Community Pharmacies in Aden City-Yemen.
Abood EA; Wazaify M
Subst Use Misuse; 2016 Jun; 51(7):942-7. PubMed ID: 27100671
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' interventions on prescription problems in one French community pharmacy: A prospective pilot study.
Castronovo A; Gervais F; Mongaret C; Slimano F
Ann Pharm Fr; 2018 Jul; 76(4):299-305. PubMed ID: 29555106
[TBL] [Abstract][Full Text] [Related]
13. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
14. Institutional control of prescription blanks.
Rapp RP; Sachatello CR
Am J Hosp Pharm; 1975 Jan; 32(1):52-4. PubMed ID: 1168414
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Medicine Abuse Trends in Community Pharmacies: The Medicine Abuse Observatory (MAO) in a Region of Southern Europe.
Perelló M; Rio-Aige K; Guayta-Escolies R; Gascón P; Rius P; Jambrina AM; Bagaria G; Armelles M; Pérez-Cano FJ; Rabanal M
Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360110
[TBL] [Abstract][Full Text] [Related]
16. Psychoactive drug prescribing in the Tasmanian community.
Jacobson GA; Friesen WT; Peterson GM; Rumble RH; Polack AE
Med J Aust; 1992 Jul; 157(1):20-4. PubMed ID: 1353603
[TBL] [Abstract][Full Text] [Related]
17. Early signal of diverted use of tropicamide eye drops in France.
Ponté C; Pi C; Palmaro A; Jouanjus E; Lapeyre-Mestre M;
Br J Clin Pharmacol; 2017 Aug; 83(8):1791-1800. PubMed ID: 28239898
[TBL] [Abstract][Full Text] [Related]
18. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
[TBL] [Abstract][Full Text] [Related]
19. [Management of acute infantile diarrhoea: a study on community pharmacy counseling in the Midi-Pyrenees region].
Lapeyre-Mestre M; Pin M
Arch Pediatr; 2004 Aug; 11(8):898-902. PubMed ID: 15288078
[TBL] [Abstract][Full Text] [Related]
20. Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator.
Pradel V; Delga C; Rouby F; Micallef J; Lapeyre-Mestre M
CNS Drugs; 2010 Jul; 24(7):611-20. PubMed ID: 20527997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
